{"data":{"id":"us-ar/ark.-code-ann.-23-79-159","jurisdiction":"us-ar","citation":"Ark. Code Ann. § 23-79-159","heading":"Notification of drug formulary changes","body":"(a) (1) A health benefit plan that provides prescription drug coverage or contracts with a third party for prescription drug services with tiered copayments shall notify an enrollee presently taking a prescription drug, in writing or electronically at the request of the enrollee, at least sixty (60) days before an increase in the enrollee's financial responsibility as a result of a modification by the health benefit plan to the health benefit plan's drug formulary. (2) Subdivision (a)(1) of this section does not apply to a generic substitution for a prescription drug. (b) This section does not apply to coverage for a drug that is determined by a pharmacy and a therapeutics committee to be subject to new safety warnings. Added by Act 2013, No. 1260,§ 1, eff. 1/1/2014.\n\n(a) (1) A health benefit plan that provides prescription drug coverage or contracts with a third party for prescription drug services with tiered copayments shall notify an enrollee presently taking a prescription drug, in writing or electronically at the request of the enrollee, at least sixty (60) days before an increase in the enrollee's financial responsibility as a result of a modification by the health benefit plan to the health benefit plan's drug formulary. (2) Subdivision (a)(1) of this section does not apply to a generic substitution for a prescription drug.\n\n(1) A health benefit plan that provides prescription drug coverage or contracts with a third party for prescription drug services with tiered copayments shall notify an enrollee presently taking a prescription drug, in writing or electronically at the request of the enrollee, at least sixty (60) days before an increase in the enrollee's financial responsibility as a result of a modification by the health benefit plan to the health benefit plan's drug formulary.\n\n(2) Subdivision (a)(1) of this section does not apply to a generic substitution for a prescription drug.\n\n(b) This section does not apply to coverage for a drug that is determined by a pharmacy and a therapeutics committee to be subject to new safety warnings.","path":["AR Code","Title 23","Chapter 79","Subchapter 1"],"source_url":"https://oss-data-us.vaquill.ai/v2026.08/us_ar_statutes.parquet","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:41Z","sha256":"a0c051246fcfc01323d2a7873e34d31bd9b7e5f85048e895f4fbd2768515be9a","source_id":"us-ar","stale":false,"prev":"us-ar/ark.-code-ann.-23-79-158","next":"us-ar/ark.-code-ann.-23-79-160"},"notice":"GroundRules: Original legal text. Not legal advice."}